Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

Title
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 9, Issue 5, Pages 293-303
Publisher
Elsevier BV
Online
2021-03-31
DOI
10.1016/s2213-8587(21)00050-4

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation